Asset Publisher

angle-left James Brophy, MD, PhD

Senior Scientist, RI-MUHC, 5252 de Maisonneuve

Cardiovascular Health Across the Lifespan Program

Centre for Outcomes Research and Evaluation

Professor, Department of Medicine, Faculty of Medicine, McGill University

Department of Medicine, Division of Cardiology, MUHC



Cardiovascular epidemiology • medical decision making.

Research Focus

My research focuses on cardiovascular epidemiology and includes pharmacoepidemiology, systematic reviews, cost-effectiveness analyses and health technology assessments.

Selected Publications

Click on Pubmed to see my current publications list

  • Bogaty P, Dagenais G, Joseph L, Boyer L, Leblanc A, Belisle P, Brophy JM. Time Variability of C-Reactive Protein: Implications for Clinical Risk Stratification. PLoS One 2013 Apr 8 8(4).

  • Etminan M, Bird ST, Delaney JA, Bressler B, Brophy JM. Isotretinoin and the risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished data. JAMA Dermatol. 2013 Feb 1;149(2):216-20

  • Mayo NE, Mackay-Lyons MJ, Scott SC, Moriello C, Brophy JM. A randomized trial of two home-based exercise programmes to improve functional walking post-stroke. Clin Rehabil. 2013 Mar 15. [Epub ahead of print]

  • Almadi MA, Barkun A, Brophy JM. Antiplatelet and anticoagulant therapy in patients with gastrointestinal bleeding. JAMA. 2011 Dec 7;306(21):2367-74. Epub 2011 Nov 1.

  • Bogaty P, Filion K, Brophy JM. Routine Invasive Management After Fibrinolysis in Patients With ST-Elevation Myocardial Infarction: A Systematic Review of Randomized Clinical Trials. BMC Cardiovasc Disord. 2011 Jun 20;11(1):34. [Epub ahead of print]